Press Releases and Announcements

Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm

Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus

Rentschler Biopharma breaks ground at new U.S. production site in greater Boston

Developing the Best Formulation Partnership

How a CDMO alliance sets new standards for drug development and commercialization

Rentschler Biopharma expands production of highly complex antibodies at German site

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

Dr. Martin Kessler joins as CEO of U.S. Subsidiary and as SVP Transformation

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

Our Experts featured in the European Biotechnology Spring Edition

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV

CEO Frank Mathias’ cover feature in Pharma’s Almanac

Diana Wiedmann, new Senior Vice President Human Relations

Biopharmaceuticals: Benefits for patients with autoimmune diseases

An Interview by Wolfram Schulze about digital client benefits

Article on formulation development with Leukocare

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement

Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine

Rentschler Biopharma optimizes time-to-market for life-saving biopharmaceuticals

Rentschler Biopharma and Vetter cooperate to accelerate biopharmaceutical manufacturing

Competitive advantages of a family-owned business

Expansion plans at U.S. site driven by innovation

The key to tackling drug development complexity: Collaboration.

Extending Collaboration with Genmab to U.S. facility

New cell line development solutions

A vision for achieving worldwide biopharmaceutical CDMO leadership

Outsourcing Services: from Gene to Patient

Collaboration with Summit Pharmaceutical International Corporation

Nikolaus F. Rentschler and Frank Mathias are "EY Entrepreneur of the Year"